Indeed, decreased expression of TGFβRI/II receptors or mutations in these proteins that abrogate TGFβ1 signaling in tumor cells have been observed in many cancer types [48,49,50,51,52,53]. The gene discussed is TGFB1; the disease is neoplasm.